Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Probuphine
    • Ropinirole Implant
    • T3 Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Company Information
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Titan FCOI Policy
    • Financial Info
    • Financials
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
  • Search

Press Releases

  • Home
  • News
  • Press Releases
News

Navigate News

  • Overview
  • Press Releases
  • Events
  • Presentations
  • In the News
  • Publications
  • Posters
  • Media Resources

Press Releases

  • All News
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Probuphine(R) Patent Issued by the U.S. Patent and Trademark Office

June 16, 2010

Titan Stock Commences Trading on the OTCBB

June 2, 2010

Titan Pharmaceuticals Announces First Quarter 2010 Financial Results

May 17, 2010

Titan Announces Completion of Re-Registration of the Company With the Securities and Exchange Commission

April 27, 2010

Titan Provides Estimate of Upcoming Royalty Payment

April 21, 2010

Titan Initiates Confirmatory Phase 3 Study of Probuphine(R) in the Treatment of Opioid Addiction

March 30, 2010

Titan Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference

February 4, 2010

Titan Pharmaceuticals Files Form 10 for Re-registration of the Company With the Securities and Exchange Commission

January 19, 2010

  • « Previous
  • 1
  • 2
© 2021 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap